The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 90
Healthy Volunteers: f
View:
• Male or female over 20 years old, diagnosed with Parkinson's disease.
Locations
Other Locations
Taiwan
Kaohsiung Medical Univeristy Hospital
RECRUITING
Kaohsiung City
Contact Information
Primary
Yang-Pei Chang, M.D.; MSc.
cyp905@gmail.com
886-7-2911101
Time Frame
Start Date: 2023-10-31
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 400
Treatments
Experimental: Miyarisan-BM (Clostridium Butyricum Miyairi) first
Miyarisan-BM (Clostridium Butyricum Miyairi) for 1 year, then stopped for 1 year
Experimental: Miyarisan-BM (Clostridium Butyricum Miyairi) later
observation for 1 year and then Miyarisan-BM (Clostridium Butyricum Miyairi) for 1 year.
Related Therapeutic Areas
Sponsors
Leads: Kaohsiung Medical University Chung-Ho Memorial Hospital